LSALT peptide
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LSALT peptide, covering 2024-11-29 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery [Phase 2]